LONDON, UK: Modern Synthesis, a biotechnology company pioneering the development of microbially-derived biomaterials, today announces the successful close of a $5.5 million funding round. The oversubscribed round was led by Extantia Capital, with participation from Artesian and Collaborative Fund. This investment will enable Modern Synthesis to...
